The push to make the lifesaving opioid overdose antidote easier to buy took five years and multiple court battles, fueling worries about access and supply.
How Emergent BioSolutions profited from Narcan s over-the-counter delay washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.
Opiant Pharmaceuticals (NASDAQ:OPNT – Get Rating) and Sonoma Pharmaceuticals (NASDAQ:SNOA – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership. Volatility & Risk Opiant Pharmaceuticals has a beta of […]
In February of 2022, the Federal Circuit affirmed a New Jersey District Court's determination that four patents claiming methods of treating opioid overdose by intranasal administration of a naloxone formulation.